Company intelligence
Asgard Therapeutics
Swedish biotech company exploring reprogramming as the next leap forward in cancer immunotherapy
Biotechnology Research
Lund, SE
28 employees
Founded 2018
1 public signals
About Asgard Therapeutics
Asgard Therapeutics is a privately held biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy. The company builds on ground-breaking and proprietary reprogramming technologies to develop gene therapy products designed to set in motion efficient and personalized immune responses. Backed by top investors, Asgard Therapeutics aims to establish a pipeline of off-the shelf cancer immunotherapies that trigger personalized anti-cancer immune responses for the benefit of cancer patients in need.
Verified activity
Signals from Asgard Therapeutics
1 published signal